Medicaid spends more on antipsychotics – including Eli Lilly’s (LLY) Zyprexa, Bristol-Myers Squibb's (BMY) Abilify, AstraZeneca’s (AZN) Seroquel and Johnson & Johnson’s (JNJ) Risperdal - than any other class of medicine. In 2008, the most recent year for which data was available, spending was $3.6 billion, up from $1.6 billion in 1999, according to Mathematica Policy Research data cited by the paper. And the number of people younger than 20 years old who receive prescriptions for antipsychotics that are paid for by Medicaid tripled during that period. http://www.pharmalive.com/feds-probe-antipsychotic-prescriptions-for-children-in-medicaid?cid=nl.phrm01 "People Who experience mood swings, fear, voices and visions"